Resveratrol Derivatives Inhibit Pro-survival Akt Signaling Pathway in Lung Cancer
Anticancer Research · 2025
DOI: 10.21873/anticanres.17667 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Bhurichaya Innets und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center of Excellence in Cancer Cell and Molecular Biology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Resveratrol, Antineoplastic Agents, Phytogenic, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Excellence in Cancer Cell and Molecular Biology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.
- Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.
- Interdisciplinary Physiology Program, Faculty of Graduate School, Chulalongkorn University, Bangkok, Thailand.
- Interdisciplinary Program in Pharmacology, Graduate School, Chulalongkorn University, Bangkok, Thailand.
- Center of Excellence in Cancer Cell and Molecular Biology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand pithi.c@chula.ac.th.
Zitieren
APA
Innets, B., Racha, S., Ei, Z. Z., Sriratanasak, N., & Chanvorachote, P. (2025). Resveratrol Derivatives Inhibit Pro-survival Akt Signaling Pathway in Lung Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.17667
Vancouver
Innets B, Racha S, Ei ZZ, Sriratanasak N, Chanvorachote P. Resveratrol Derivatives Inhibit Pro-survival Akt Signaling Pathway in Lung Cancer. Anticancer Research. 2025. doi:10.21873/anticanres.17667
BibTeX
@article{Innets2025,
author = {Innets, Bhurichaya and Racha, Satapat and Ei, Zin Zin and Sriratanasak, Nicharat and Chanvorachote, Pithi},
title = {Resveratrol Derivatives Inhibit Pro-survival Akt Signaling Pathway in Lung Cancer},
journal = {Anticancer Research},
year = {2025},
doi = {10.21873/anticanres.17667}
}
EUVIMED